MSR1 is not required for obesity-associated inflammation and insulin resistance in mice

被引:0
|
作者
Nance, Sierra A. [1 ,2 ]
Muir, Lindsey [3 ]
Delproprosto, Jennifer [2 ]
Lumeng, Carey N. [1 ,2 ]
机构
[1] Univ Michigan, Mol & Integrat Physiol, Med Sch, 109 Zina Pitcher Pl,2057 BSRB, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pediat, Med Sch, 109 Zina Pitcher Pl,2057 BSRB, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Computat Med & Bioinformat, Med Sch, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
ADIPOSE-TISSUE; LOCAL PROLIFERATION; INTERLEUKIN-6; PROTECTION; ALPHA;
D O I
10.1038/s41598-023-29736-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity induces a chronic inflammatory state associated with changes in adipose tissue macrophages (ATMs). Macrophage scavenger receptor 1 (MSR1) has been implicated in the regulation of adipose tissue inflammation and diabetes pathogenesis; however, reports have been mixed on the contribution of MSR1 in obesity and glucose intolerance. We observed increased MSR1 expression in VAT of obese diabetic individuals compared to non-diabetic and single nuclear RNA sequencing identified macrophage-specific expression of MSR1 in human adipose tissue. We examined male Msr1(-/-) (Msr1KO) and WT controls and observed protection from obesity and AT inflammation in non-littermate Msr1KO mice. We then evaluated obese littermate Msr1(+/-) (Msr1HET) and Msr1KO mice. Both Msr1KO mice and Msr1HET mice became obese and insulin resistant when compared to their normal chow diet counterparts, but there was no Msr1-dependent difference in body weight, glucose metabolism, or insulin resistance. Flow cytometry revealed no significant differences between genotypes in ATM subtypes or proliferation in male and female mice. We observed increased frequency of proliferating ATMs in obese female compared to male mice. Overall, we conclude that while MSR1 is a biomarker of diabetes status in human adipose tissue, in mice Msr1 is not required for obesity-associated insulin resistance or ATM accumulation.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Normalization of obesity-associated insulin resistance through immunotherapy
    Winer, Shawn
    Chan, Yin
    Paltser, Geoffrey
    Truong, Dorothy
    Tsui, Hubert
    Bahrami, Jasmine
    Dorfman, Ruslan
    Wang, Yongqian
    Zielenski, Julian
    Mastronardi, Fabrizio
    Maezawa, Yuko
    Drucker, Daniel J.
    Engleman, Edgar
    Winer, Daniel
    Dosch, H. -Michael
    NATURE MEDICINE, 2009, 15 (08) : 921 - U126
  • [22] Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis
    Beloor, Jagadish
    Ullah, Irfan
    Kim, Jongkil
    Choi, Changseon
    Kim, Sunghwa
    Chung, Kunho
    Kr, Jyothi
    Yi, Yujong
    Rhim, Taiyoun
    Kumar, Priti
    Lee, Sang-Kyung
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 54 (04) : 519 - 537
  • [23] Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
    Zhang, Lei
    Han, Yi-Jing
    Zhang, Xian
    Wang, Xin
    Bao, Bin
    Qu, Wei
    Liu, Jian
    DIABETOLOGIA, 2016, 59 (10) : 2219 - 2228
  • [24] The Dual-Specificity Phosphatase 2 (DUSP2) Does Not Regulate Obesity-Associated Inflammation or Insulin Resistance in Mice
    Lancaster, Graeme I.
    Kraakman, Michael J.
    Kammoun, Helene L.
    Langley, Katherine G.
    Estevez, Emma
    Banerjee, Ashish
    Grumont, Raelene J.
    Febbraio, Mark A.
    Gerondakis, Steve
    PLOS ONE, 2014, 9 (11):
  • [25] Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
    Lei Zhang
    Yi-Jing Han
    Xian Zhang
    Xin Wang
    Bin Bao
    Wei Qu
    Jian Liu
    Diabetologia, 2016, 59 : 2219 - 2228
  • [26] Cholinergic activation by galantamine suppresses obesity-associated inflammation in mice
    Pavlov, Valentin
    Satapathy, Sanjaya
    Ochani, Mahendar
    Dancho, Meghan
    Hudson, LaQueta
    Rosas-Ballina, Mauricio
    Valdes-Ferrer, Sergio
    Olofsson, Peder
    Harris, Yael
    Chavan, Sangeeta
    Roth, Jesse
    Tracey, Kevin
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [27] NADPH Oxidase and (-)-Epicatechin in the Modulation of Obesity-Associated Insulin Resistance
    Cremonini, Eleonora
    Oteiza, Patricia I.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S172 - S172
  • [28] Mechanisms of obesity-associated insulin resistance: many choices on the menu
    Qatanani, Mohammed
    Lazar, Mitchell A.
    GENES & DEVELOPMENT, 2007, 21 (12) : 1443 - 1455
  • [29] Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?
    Ukkola, O
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (05) : 571 - 574
  • [30] Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance
    Zhou, Meiyi
    Shao, Jing
    Wu, Cheng-Yang
    Shu, Le
    Dong, Weibing
    Liu, Yunxia
    Chen, Mengping
    Wynn, R. Max
    Wang, Jiqiu
    Wang, Ji
    Gui, Wen-Jun
    Qi, Xiangbing
    Lusis, Aldons J.
    Li, Zhaoping
    Wang, Weiqing
    Ning, Guang
    Yang, Xia
    Chuang, David T.
    Wang, Yibin
    Sun, Haipeng
    DIABETES, 2019, 68 (09) : 1730 - 1746